Benzotriazonine as a new core structure for the design of CCK-receptor antagonists

Journal of Peptide Science

Volumn 5, Issue 3, 1999, Pages 155-158

  Escherich, Achim ^a   Escrieut, Chantal ^b   Fourmy, Daniel ^b   Moroder, Luis ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b CHU RANGUEIL   (France)

Author keywords

Benzotriazonine; CCK; CCK receptor antagonists; Gastrin; Peptide hormone

Indexed keywords

BENZOTRIAZONINE DERIVATIVE; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ B RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; PRIORITY JOURNAL;

ANIMALS; CHO CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRICETINAE; CRYSTALLIZATION; DRUG DESIGN; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZINES;

EID: 0032950157     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1387(199903)5:3<155::AID-PSC195>3.0.CO;2-E     Document Type: Article

References (11)

1. M.G. Bock, R.M. Freidinger, S.B. Freedman and V.G. Matassa (1995). Cholecystokinin (CCK) receptor antagonists. Curr. Pharm. Design 1, 279-294.
2. R.M. Freidinger (1989). Cholecystokinin and gastrin antagonists. Med. Res. Rev. 9, 271-290.
3. G. Curoto, D. Donati, G. Pentassuglia and A. Ursini (1995). 1,5-Benzodiazepines as CCK-B antagonists. Effect of halogen substitution at the benzo-fused ring on potency and selectivity. Bioorg. Med. Chem. Lett. 5, 3011-3016.
4. R.S.L. Chang and V.J. Lotti (1986). Biochemical and pharmacological characterization of an extremely potent and selective non-peptide cholecystokinin antagonist. Proc. Natl. Acad. Sci. USA 83, 4923-4926.
5. V.J. Lotti and R.S.L. Chang (1989). A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365260. Eur. J. Pharmacol. 162, 273-280.
6. M.J. Yu, K.J. Thrasher, J.R. Jefferson, J.R. McCowan, N.R Mason and L.G. Mendelsohn (1991). Quinazolinone cholecystokinin-B receptor ligands. J. Med. Chem. 34, 1505-1508.
7. S.E. Gibson, N. Guillo, S.B. Kalindjian and M.J. Tozer (1997). Incorporation of conformationally constrained phenylalanine derivatives Tic, Sic, Hic and Nic into a cholecystokinin-B/gastrin receptor antagonist. Bioorg. Med. Chem. Lett. 7, 1289-1292.
8. E. Miklciuk-Olasik (1992). Synthesis of new derivatives of 2,3,4,5,6,7-hexahydro-1H-1,4,7-benzotriazonine with expected biological activity. Pharmazie 47, 711-712.
9. D. Trist, G. Pentassuglia, M.E. Tranquillini, A. Ursini (1993). Carbamate derivatives and their use in medicine. PCT Int. Appl. WO 93/14075, Verona, Italy.
10. E. Mikiciuk-Olasik (1990). Synthesis of new derivatives of 2,3,4,5,6,7-hexahydro-1H-1,4,7-benzotriazonine. Pharmazie 45, 436-437.
11. V. Gigoux, C. Escrieut, S. Silvente-Poirot, B. Maigret, L. Gouilleux, J.A. Fehrentz, D. Gully, L. Moroder, N. Vaysse and D. Fourmy (1998). Met 195 of the CCK-A receptor interacts with the sulfated tyrosine of CCK and is crucial for receptor transition to high affinity state. J. Biol. Chem. 273, 14380-14386.